Back to News
Market Impact: 0.45

JPMorgan lowers United Breweries stock price target on monsoon impact

NYTJPMUBBLVSATSPNS
Analyst InsightsCompany FundamentalsAnalyst EstimatesNatural Disasters & WeatherCorporate Guidance & OutlookConsumer Demand & RetailInvestor Sentiment & PositioningArtificial Intelligence
JPMorgan lowers United Breweries stock price target on monsoon impact

JPMorgan has reduced its price target for United Breweries Ltd. to INR2,050.00 from INR2,200.00, while maintaining an Overweight rating, citing challenging Q2 FY26 conditions due to adverse monsoon weather impacting summer-centric product sales and leading to an approximate 8% reduction in FY26-27E EBITDA estimates. Despite forecasting a short-term low single-digit volume decline, the firm remains positive on UBBL's medium-term prospects for market share gains and expects volume growth recovery in H2 FY26, suggesting the stock's recent 10% correction offers a good entry opportunity.

Analysis

JPMorgan has adjusted its outlook on United Breweries Ltd. (UBBL), reducing its price target to INR 2,050.00 from INR 2,200.00 while reiterating an 'Overweight' rating. The target revision is a direct response to anticipated short-term challenges in the second quarter of fiscal year 2026, where above-average monsoon rainfall has negatively impacted sales of summer-centric products. This has led to volume declines in key markets during July-August, prompting JPMorgan to forecast a low single-digit volume decline for the quarter and subsequently reduce its FY26-27E EBITDA estimates by approximately 8%. Despite these near-term headwinds, the firm's medium-term thesis remains positive, projecting a volume growth recovery to 6-7% in the second half of FY26 and over FY26-27E. This optimism is predicated on UBBL's potential for market share gains through strategic initiatives in distribution, premiumization, and brand building. The analysis notes that UBBL's stock has corrected 10% over the past two months against a flat NIFTY index, a divergence that JPMorgan interprets as a favorable entry point for investors.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo